Clinical responses of patients with diffuse leptomeningeal glioneuronal tumors to chemotherapy
Authors:
- 30 September 2017
- journal article
- research article
- Published by Springer Nature in Child's Nervous System
- Vol. 34 (2) , 329-334
Abstract
Diffuse leptomeningeal glioneuronal tumors (DLGT) have been recognized in the most recent WHO classification as a distinct entity.Keywords
This publication has 11 references indexed in Scilit:
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Disseminated oligodendroglial cell-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entityJournal of Neuro-Oncology, 2015
- Diffuse Leptomeningeal Neuroepithelial TumorAmerican Journal of Surgical Pathology, 2013
- Outcome of Patients With Pilocytic Astrocytoma and Leptomeningeal DisseminationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entityActa Neuropathologica, 2012
- Spinal low-grade neoplasm with leptomeningeal dissemination mimicking tuberculous meningitis in a childChild's Nervous System, 2010
- Diffuse Leptomeningeal Glioneuronal Tumors: A New Entity?Brain Pathology, 2010
- Neurocytoma-like neoplasm of the thoracic spine in a 15-month-old child presenting with diffuse leptomeningeal dissemination and communicating hydrocephalusJournal of neurosurgery. Pediatrics, 2005
- Spinal low-grade neoplasms with extensive leptomeningeal dissemination in childrenChild's Nervous System, 2002
- A Case of Diffuse Leptomeningeal Oligodendrogliomatosis Associated with HHV-6 Variant ANeuropediatrics, 2002